Annual program will award funding to early-career healthcare professionals advancing research, education, and innovation in ...
VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on ...
Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, ...
YOKOHAMA, Japan, Oct. 6, 2026 /PRNewswire/ -- Highlighting regional life sciences innovation, 17 Taiwanese biotech companies ...
The 30,000-square-foot New Jersey Innovation Hub at HELIX offers laboratory space and other resources to early-stage ...
VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA” or the “Company”), a leading developer of next-generation antibody-based cancer therapies, today provided an update on its strategy and progress to implement ...
Times Now World on MSN
King Charles inspects innovative contraceptive project to protect native red squirrels
King Charles visited a North Yorkshire research facility to review a non-lethal contraceptive project aimed at controlling the invasive grey squirrel population, which threatens Britain's native red ...
Every year, numerous biotechnology innovations demonstrate promising results in the laboratory. Yet many of them never ...
While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...
Chinese biotechs can run trials 50–70% faster – our report shows where that speed is paying off, and where the road narrows.
Biotech Open Platform has inaugurated a new biotechnology platform in Clermont-Ferrand, France, as it seeks to bridge the gap between laboratory development and industrial-scale production while ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of David Liu, M.D., Ph.D., as Executive Vice President and Chief Medical Officer (CMO), effective October 12, 2026. Dr. Liu will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results